UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in CLDX — Celldex Therapeutics, Inc.
CIK 861177
NEW YORK, NY
Position in CLDX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$5,021,783
+$1,189,789 QoQ
Shares Held
134,958
+11.7% QoQ
Ownership
0.172%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#72
of 252 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 54%
Shared 0%
None 46%
Common Shares in CLDX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,385,897,555 across 206 Biotechnology names. CLDX ranks #61 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,086,683 | $1,533,248,041 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
716,560 | $446,803,817 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
727,848 | $219,104,078 | |
| 4 | INCY |
Incyte Corp
|
1,508,720 | $171,028,494 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
912,335 | $170,862,094 | |
| 6 | INSM |
INSMED Inc
|
1,335,071 | $142,345,265 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
1,454,672 | $115,340,938 | |
| 8 | MRNA |
Moderna, Inc.
|
1,521,849 | $106,575,080 |
All Filings in CLDX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,021,783 | 134,958 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $3,831,994 | 120,807 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $3,193,713 | 117,589 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $2,728,713 | 105,478 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $4,351,762 | 213,846 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $2,383,019 | 131,296 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $2,939,328 | 116,317 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $3,487,202 | 102,595 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $3,565,022 | 96,326 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,624,615 | 38,709 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,382,863 | 34,868 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $959,566 | 34,868 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,077,207 | 31,748 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $1,142,291 | 31,748 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,347,885 | 30,242 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $850,101 | 30,242 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $793,674 | 29,439 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $1,127,010 | 33,089 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,278,557 | 33,089 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,954,977 | 36,210 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,137,360 | 34,012 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $728,766 | 35,377 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $595,452 | 33,987 | Shares | Sole | 2021-03-01 | |
| No filing history on record for this holder in this stock. | ||||||